基于纳米粒子的免疫疗法用于逆转T细胞耗尽
Fei Li1, Yahong Wang2, Dandan Chen2
1Institute of Pathogen Biology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
International journal of molecular sciences
|February 10, 2024
概括
基于纳米粒子的免疫疗法在逆转T细胞枯竭方面表现有前途,这是慢性感染和癌症中出现的功能障碍. 本综述探讨了有针对性的纳米粒子策略,以克服当前治疗局限性并改善结果.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- T细胞耗尽是治疗慢性感染和癌症的关键障碍.
- 目前的免疫检查点阻塞疗法 (例如PD-1,TIM-3) 在逆转T细胞枯竭方面存在局限性.
- 纳米技术为癌症和传染病治疗提供了新的药物输送系统.
研究的目的:
- 审查T细胞枯竭的最新进展,重点关注可向的特征.
- 讨论新兴的以纳米粒子为基础的免疫治疗输送系统.
- 详细介绍基于纳米粒子的免疫疗法,用于逆转T细胞疲劳.
主要方法:
- 关于T细胞耗尽机制的文献综述.
- 对纳米粒子在药物输送和免疫治疗中的应用进行分析.
- 针对免疫检查点,瘤微环境和T细胞代谢的基于纳米粒子的策略的汇编.
主要成果:
- 基于纳米粒子的免疫疗法是克服T细胞枯竭的有希望的方法.
- 用纳米粒子准免疫检查点,瘤微环境和T细胞代谢可以逆转疲劳.
- 纳米粒子输送系统可以提高免疫疗法的有效性.
结论:
- 基于纳米粒子的免疫疗法在治疗T细胞枯竭方面提供了新的前沿.
- 了解耗尽特征是开发有效纳米粒子战略的关键.
- 这些方法具有预防和治疗慢性疾病和癌症的潜力.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910


